The three fates of immunosuppression in the next millenium: selectivity, synergy, and specificity.
Kahan
B D
BD
D000818:Animals; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects
D007166:Immunosuppressive Agents